Table I. Summary of provisional cases of selected notifiable diseases, United States, cumulative, week ending October 30, 2004
Categories: DiseasesTABLE 1. Summary of provisional cases of selected notifiable diseases,
United States, cumulative, week ending October 30, 2004 (43rd Week) *
Cum. Cum.
2004 2003
Anthrax – –
Botulism: – –
foodborne 11 11
infant 60 56
other (wound & unspecified) 9 26
Brucellosis ([dagger]) 85 82
Chancroid 30 50
Cholera 4 1
Cyclosporiasis ([dagger]) 203 61
Diphtheria – 1
Ehrlichiosis: – –
human granulocytic (HGE) ([dagger]) 259 273
human monocytic (HME) ([dagger]) 237 221
human, other and unspecified 27 38
Encephalitis/Meningitis: – –
California serogroup viral ([dagger]) 74 106
([section])
eastern equine ([dagger]) ([section]) 3 13
Powassan ([dagger]) ([section]) – –
St. Louis ([dagger]) ([section]) 7 40
western equine ([dagger]) ([section]) – –
Hansen disease (leprosy) ([dagger]) 69 68
Hantavirus pulmonary syndrome ([dagger]) 17 18
Hemolytic uremic syndrome, postdiarrheal 119 141
([dagger])
HIV infection, pediatric ([dagger]) 126 169
([paragraph])
Influenza-associated pediatric – NA
mortality **
Measles, total 23 ([dagger] 51 ([sub-
[dagger]) section])
Mumps 162 177
Plague 1 1
Poliomyelitis, paralytic – –
Psittacosis ([dagger]) 9 11
Q fever ([dagger]) 60 56
Rabies, human 3 2
Rubella 10 7
Rubella, congenital syndrome – 1
SARS-associated coronavirus disease – 8
([dagger]) **
Smallpox ([dagger]) – NA
([paragraph][paragraph])
Staphylococcus aureus: – –
Vancomycin-intermediate (VISA) – NA
([dagger]) ([paragraph][paragraph])
Vancomycin-resistant (VRSA) ([dagger]) 1 NA
([paragraph][paragraph])
Streptococcal toxic-shock 89 136
syndrome ([dagger])
Tetanus 14 16
Toxic-shock syndrome 106 103
Trichinosis 4 1
Tularemia ([dagger]) 74 74
Yellow fever – –